Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle

Life Science

Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month

Life Science

Defensive Plays for a Bear Market: 3 Healthcare Stocks with Robust Dividends

Life Science

Three Canadian Growth Stocks Garner Unanimous “Strong Buy” Ratings from Analysts

Life Science

How is Pfizer Planning for the Future Under the Patent Cliff?

Life Science

Vertex Pharmaceuticals: Poised to Outpace Pfizer on Compelling Growth Story

Life Science

Defying Market Trend, Biotechnology Company Glaukos Soars Nearly 14%

Life Science

Seeking Certainty in Growth Stocks: Where to Invest for 2025

Financial Service, Life Science, Technology

Guardant Health Shares Soar 28% on Blowout Quarterly Results, Surging Test Volumes

Life Science

Who Will Be the Next Winner in the Weight-Loss Drug Market? BioAge Labs Attracts Attention

Life Science

With Yields Exceeding 5%, These Two High-Dividend Stocks Are Worth Watching

Consumer Goods, Life Science

Trump’s Price-Cutting Vow Rattles Novo Nordisk, But Valuation and Pipeline Offer Compelling Case

Life Science

Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential

Life Science

It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks

Life Science

BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain

Life Science